BLRX
Biolinerx Ltd.
An Israeli biopharmaceutical company that finds promising experimental drugs from academic labs and biotech startups and shepherds them through clinical trials. Its first FDA-approved medicine, APHEXDA, helps mobilize stem cells for transplant, and it is also developing treatments for hard-to-treat cancers. Founded in 2003 as a joint venture backed by Teva, the Hadassah Medical Center's tech-transfer arm, and the Jerusalem Development Authority, its name blends "bio," "pipeline," and "Rx" (the medical prescription symbol).
ADRUnderlying: BLRXCUSIP: 09071M205HealthcareIL2 holders
American Depositary Shares, each representing 600 ordinary shares
Recent Activity
2022Q2
1 sell
-676 shares
-676 shares
2022Q1
2 sells
-1.06M shares
ARK InvestEXIT
-1.06M shares
-1.20M shares(-99.9%)
-1.20M shares(-99.9%)
Loading more activity...